Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOS | P01100 | 1/20 | 0.72 |
| ▸ | JUN | P05412 | 1/20 | 0.72 |
| ▸ | BCHE | P06276 | 1/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.69 |
| ▸ | MAOB | P27338 | 5/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.62 |
| ▸ | MAOA | P21397 | 2/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30584119 | 1.00 | FOS (0.72) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL80787 | 1.00 | FOS (0.72) | FOSJUNBCHEKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL8098406 | 0.98 | FOS (0.70) | FOSJUNBCHEKDM4EALDH1A1 | |
| Nitrous Acid SCHEMBL28876505 | 0.94 | FOS (0.65) | FOSJUNBCHEKDM4EALDH1A1 | |
| Alcohol SCHEMBL28250208 | 0.94 | KDM4E (0.71) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL10467107 | 0.91 | FOS (0.74) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL10467106 | 0.91 | FOS (0.74) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL28500089 | 0.91 | FOS (0.61) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL5623308 | 0.90 | FOS (0.60) | FOSJUNBCHEKDM4EALDH1A1 | |
| SCHEMBL9379839 | 0.89 | THRB (0.64) | FOSJUNBCHEKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 872 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| CN-118027276-A | Multipolymer, preparation method and application thereof, negative electrode slurry, negative electrode plate and lithium ion battery | 北京卫蓝新能源科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117388421-A | Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics | 中国农业大学 | 2024-01-12 | — | — | CN | claimed |
| US-20230390195-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | DELPOR, INC. | 2023-12-07 | — | — | US | claimed |
| US-20220280494-A1 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | DELPOR, INC. | 2022-09-08 | — | — | US | claimed |
| CN-114641291-A | Compositions of small molecule therapeutic compounds | 戴尔普尔有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-114438149-A | Method for synthesizing benzylisoquinoline alkaloid by constructing biological cascade reaction | 上海交通大学 | 2022-05-06 | — | — | CN | claimed |
| CN-113024573-A | Epodophyllotoxin derivative, preparation method and application thereof in preparation of antitumor drugs | 江苏百奥信康医药科技有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-112004538-A | Compositions of small molecule therapeutic compounds | 德尔宝股份有限公司 | 2020-11-27 | — | — | CN | claimed |
| EP-3515408-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | Delpor, Inc. (US) | 2019-07-31 | — | — | EP | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050161666-A1 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-07-28 | — | — | US | claimed |
| US-6916890-B1 | Thermally reworkable epoxy resins and compositions based thereon | HENKEL CORPORATION (US) | 2005-07-12 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| WO-2003031492-A1 | THERMALLY REWORKABLE EPOXY RESINS AND COMPOSITIONS BASED THEREO N | HENKEL CORPORATION (US) | 2003-04-17 | — | — | WO | claimed |
| US-6451334-B2 | PULSE ADMINISTERING OF A C1-C4 SUBSTITUTED AND/OR PHENYL SUBSTITUTED CARBOXYLIC ACID AND SALTS AND A CARRIER OR DILUENT TO STIMULATE CELLS IN TREATING BLOOD DISORDERS, E.G. SICKLE CELL ANEMIA, THALASSEMIA, BLOOD LOSS ETC. | Perrine, Susan P. | 2002-09-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | FOS 3233/4885JUN 2968/4885BCHE 805/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | FOS 3373/4885JUN 1337/4885BCHE 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.